5-hydroxymethylcytosine has been researched along with Benign Monoclonal Gammopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatti, P; Chiu, BC; Derman, BA; He, C; Jakubowiak, A; Karpus, J; Langerman, SS; Luo, L; Sukhanova, M; Zhang, S; Zhang, W; Zhang, Z | 1 |
1 other study(ies) available for 5-hydroxymethylcytosine and Benign Monoclonal Gammopathies
| Article | Year |
|---|---|
Genome-wide profiling of 5-hydroxymethylcytosines in circulating cell-free DNA reveals population-specific pathways in the development of multiple myeloma.
Topics: 5-Methylcytosine; Cell-Free Nucleic Acids; Humans; Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma | 2022 |